Treatment of ragweed pollionosis using sublingual allergens

Cover Page
Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


Seasonal allergic rhinitis and conjunctivitis, caused by ragweed pollen in the south of Russia, are the most common reasons to take medical advice for sensitized patients from August to September. Sublingual immunotherapy (slASIT) using ragweed sublingual tablet «Ragvizax®», which was registered in Russia in 2019 provides qualified medical care for patients with ragweed pollen allergy. It is known that ASIT is the basic therapy, that modifies pollen allergy progression. Easy to use, high safety and efficacy profile of slASIT with «Ragvizax®» will help to improve allergists and patients compliance.

Full Text

Restricted Access

About the authors

O P Ukhanova

Federal State Budgetary Educational Institution of Higher Education Stavropol State Medical University

Email: uhanova_1976@mail.ru
Stavropol, 355017, Russian Federation

I I Ebzeeva

Federal State Budgetary Educational Institution of Higher Education Stavropol State Medical University

Stavropol, 355017, Russian Federation

References

  1. Creticos PS, Pfaar O Ragweed sublingual tablet immunotherapy: part I - evidence based clinical efficacy and safety. Immunotherapy. 2018;10(7):605-616. DOI: org/10.2217/ imt-2017-0186.
  2. Seebens H, Essl F, Dawson W, Fuentes N, Moser D et al. Global trade will accelerate plant invasions in emerging economies under climate change. Glob Chang Biol. 2015;21(11):4128-4140. doi: 10.1111/gcb.13021.
  3. Ковалев ОВ. Расселение адвентивных растений рода амброзиевых в Евразии и разработка биологической борьбы с сорняками рода Ambrosia L. (Ambrosieae, Asteraceae). В кн.: Теоретические основы биологической борьбы с амброзией. Под ред. Ковалева О.В., Белокобыльского С.А. Л.: Наука: Ленинградское отделение, 1989;189:7-23
  4. Марьюшкина ВЯ. Амброзия полыннолистная и основы биологической борьбы с ней. Киев: Наукова думка. 1986:120
  5. Москаленко ГП. Карантинные сорные растения России. М.: Гос. инспекция по карантину растений Рос. Федерации (Росгоскарантин). 2001:277
  6. Reznik SYa. Common ragweed (Ambrosia artemisiifolia L.) in Russia: spread, distribution, abundance, harmfulness, and control measures. Ambroisie, the first international ragweed review. 2009;26:88-97.
  7. Tosi A. Wüthrich B, Bonini M, Pietragalla-Köhler B. Time lag between Ambrosia sensitization and Ambrosia allergy: a 20-year study (1989-2008) in Legnano, northern Italy. Swiss Med Wkly. 2011;141:w13253. doi: 10.4414/smw.2011.13253.
  8. Уханова ОП, Богданова МА, Желтова ИВ, Малахова МК. Результаты мониторинга пыльцы и плесени в атмосферном воздухе Юга России в 2018 году. Российский Аллергологический Журнал. 2019;16(1):154-155
  9. Чурюкина ЭВ, Кит ММ, Уханова ОП, Лебеденко АА, Голошубова ЕА. Оценка данных компонентной диагностики и аэропалинологического мониторинга пыльцы в Ростовской области Юга России у больных сезонным аллергическим ринитом. Второе Московское совещание по молекулярной аллергологии (19.11.2019). Постер. С. 8
  10. Lake IR, Jones NR, Agnew M, Goodess CM, Giorgi F, Hamaoui-Laguel L. Climate Change and Future Pollen Allergy in Europe. Map adapted from Environ Health Perspect. Environ Health Perspect. 2017;125(3):385-391.
  11. Wopfner N, Bauer R, Thalhamer J, Ferreira F, Chapman M. Immunologic analysis of monoclonal and immunoglobulin E antibody epitopes on natural and recombinant Amb a 1. Clin Exp Allergy. 2008;38(1):219-226.
  12. Taramarcaz P The Ragweed invasion allergy. Clin Immunol Int J World Allergy Org. 2006;19(1):35-36.
  13. Wurtzen PA, Hoof I, Christensen LH, Vaczy Z, Henmar H, Salamanca G. Diverse and highly cross-reactive T-cell responses in ragweed allergic patients independent of geographical region. Allergy. 2019; Available at: https://onlinelibrary. wiley.com/doi/abs/10.1111/all.13992. Ссылка активна на 10.12.2019 г. doi: 10.1111/all.13992.
  14. Chen KW, Marusciac L, Tamas PT, Valenta R, Panaitescu C. Int Arch Allergy Immunol. 2018;176(3-4):163-180. doi: 10.1159/00048799.
  15. Wüthrich B, Bonini M, Pietragalla-Köhler B, Tosi A. Time lag between Ambrosia sensitisation and Ambrosia allergy: a 20-year study (1989-2008) in Legnano, northern Italy. Swiss Med. Wkly. 2011;141:w13253. Available at: https://smw.ch/ article/doi/smw.2011.13253 Ссылка активна на 10.12.2019 г. doi: 10.4414/smw.2011.13253.
  16. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy (Suppl. 86). 2008;63:1-160.
  17. EAACI Global Atlas of Allergic Rhinitis and Chronic Rhinosinusitis 2015 update. Available at: http://www.eaaci.org/ globalatlas/ENT_Atlas_web.pdf Last accessed July 2019.
  18. Enberg RN, Leickly FE, McCullough J, Bailey J, Ownby DR. Watermelon and ragweed share allergens. J Allergy Clin Immunol. 1987;79:867-753.
  19. Egger M, Mutschlechner S, Wopfner N, Gadermaier G, Briza P, Ferreira F. Pollen-food syndromes associated with weed pollinosis: an update from the molecular point of view. Allergy. 2006:61:461-476. doi: 10.1111/j.1398-9995.2006.00994.x.
  20. Bousquet J, Pfaar O, Togias A. ARIA 2019 Care pathways for allergen immunotherapy. Allergy. 2019;74:2087-2102. doi: 10.1111/all.13805.
  21. Аллергология. Фармакотерапия без ошибок. Руководство для врачей. Под ред. РМ. Хаитова. М.: «Е-ното». 2013:496
  22. Курбачева ОМ. Клинические, патогенетические и экономические аспекты применения аллерген-специфической иммунотерапии. Диссертация д-ра мед. наук. М., 2007, 198 с
  23. Passalacqua G, Canonica GW, Bagnasco D. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma. Curr Allergy Asthma Rep. 2016;16:12-88. doi: 10.1007/s11882-016-0666-x.
  24. Larenas-Linnemann D. Patient selection for subcutaneous versus sublingual immunotherapy. Curr Opin Allergy Clin Immunol. 2015;15:588-595. doi: 10.1097/ACI.0000000000000219.Ragwizax® Summary of Product Characteristics DocID: SMPC77661 - 1.0 https://grls.rosminzdrav.ru/GRLS.aspx-?RegNumber. Ссылка активна на 10.12.2019 г.
  25. Ohashi-Doi K, Lund K, Ipsen H, Andersen PS, Mosbech H, Virchow J. Poster presentation at EAACI; 26-30 May 2018: Munich, Germany. PDS 04, Poster 0253.
  26. Masuyama K, Okamoto Y, Okamiya K, Azuma R et al. Efficacy and safety of SQ house dust mite sublingual immunotherapytablet in Japanese children. Allergy. 2018;73:2352-2363. doi: 10.1111/all.13544.
  27. Lund K, Kito H, Skydtsgaard MB, Nakazawa H, Ohashi-Doi K, Lawton S. The Importance of Tablet Formulation Российский Аллергологический Журнал. 2019; 16(4) on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations. Clin Ther. 2019;41(4):742-753. doi: 10.1016/j.clinthera.2019.02.008.
  28. Ohashi-Doi K, Kito H, Nakazawa H, Ipsen H, Gudmann P, Lund K. Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation. Int Arch Allergy Immunol. 2017;174:26-34. doi: 10.1159/000479693.
  29. Nolte H, Hebert J, Berman G, Gawchik S. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Ann Allergy Asthma Immunol. 2013;110(6):450-456. DOI: 10.1016/j. anai.2013.03.013.
  30. Creticos PS, Maloney J, Bernstein DI, Casale T, Kaur A, Fisher R. Efficacy and safety of ragweed SLIT-tb in NA and EU adults. (52-wk single season trial, n=784). J Allergy Clin Immunol. 2013;131:1342-1349. doi: 10.1016/j.jaci.2013.03.019.
  31. Maloney J. et al. Safety and tolerability of dual SQ-Grass and SQ-Ragweed SLIT-tb administration (US trial). J Allergy Clin Immunol Pract. 2016;4:301-309. DOI: 10.1016/j. jaip.2015.11.004.
  32. Nolte H, Amar N, Bernstein DI, Lanier BQ, Creticos P, Berman G. Safety and tolerability of Ragweed SLIT-tb. Ann. Allergy Asthma Immunol. 2014;113:93-100. DOI: 10.1016/j. anai.2014.04.018.
  33. Kim H, Waserman S, Hebert J, Blaiss M, Nelson H, Creticos P. Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis. Allergy Asthma Clin Immunol. 2014;10:10-55. doi: 10.1186/17101492-10-55.
  34. Nelson HS. Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek®) for the treatment of allergic rhinitis. Expert Rev Clin Immunol. 2018;14(12):1003-1011. doi: 10.1080/1744666X.2018.1538788.

Statistics

Views

Abstract - 42

PDF (Russian) - 1

PlumX

Article Metrics

Metrics Loading ...

Dimensions


Copyright (c) 2019 Russian Allergological Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies